Table 3 Water mediated one-pot synthesis of quinoxalinesa
J = 8.0 Hz), 8.13 (t, 2 H, J = 8.5 Hz), 7.89–7.84 (m, 2 H),
7.61–7.57 (m, 3H); 13C NMR (DMSO-d6, 125 MHz) d 152.17,
144.96, 142.60, 142.28, 137.23, 131.83, 131.63, 131.11, 130.41,
130.32, 130.05, 128.66; ESI-MS [M+H+]: m/z = 207.
Acknowledgements
Entry Substrate 6
Product
Yield (%)b
62
The authors thank the NSFC of China (20775069), NSFC
of Zhejiang province (Z206510) and NCET-06–0520 of the
National Ministry of Education of China for financial support
on this work. We also thank professor Henry Rudler (Universite´
Pierre et Marie Curie) for his valuable discussion on this work.
1
7a
2
3
7b
57
References
1 (a) For recent reviews, seeS. Bhattacharya and P. Chaudhuri, Curr.
Med. Chem., 2008, 15, 1762; (b) D. A. Horton, G. T. Bourne and
M. L. Smythe, Chem. Rev., 2003, 103, 893; (c) M. Boiani and M.
Gonza´lez, Mini-Rev. Med. Chem., 2005, 5, 409.
7c 82
2 (a) P. N. Preston, Chem. Rev., 1974, 74, 279; (b) H. Al Muhaimeed,
J. Int. Med. Res., 1997, 25, 175; (c) L. J. Scott, C. J. Dunn, G.
Mallarkey and M. Sharp, Drugs, 2002, 62, 1503; (d) P. Venkatesan,
J. Antimicrob. Chemother., 1998, 41, 145.
3 (a) W. A. Denny, G. W. Rewcastle and B. C. Baguley, J. Med.
Chem., 1990, 33, 814; (b) L. K. Labanauskas, A. B. Brukstus, P. G.
Gaidelis, V. A. Buchinskaite, E. B. Udrenaite and V. K. Dauksas,
Pharm. Chem. J., 2000, 34, 353; (c) B. Can-Eke, M. O. Puskullu,
E. Buyukbingol and M. Iscan, Chem.-Biol. Interact., 1998, 113,
65; (d) A. Benazzouz, T. Boraud, P. Dube´dat, A. Boireau, J.-M.
Stutzmann and C. Gross, Eur. J. Pharmacol., 1995, 284, 299; (e) R.
Sevak, A. Paul, S. Goswami and D. Santini, Pharmacol. Res., 2002,
46, 351.
4 (a) G.-D. Zhu, V. B. Gandhi, J. Gong, S. Thomas, Y. Luo, X. Liu, Y.
Shi, V. Klinghofer, E. F. Johnson, D. Frost, C. Donawho, K. Jarvis,
J. Bouska, K. C. Marsh, S. H. Rosenberg, V. L. Giranda and T. D
Penning, Bioorg. Med. Chem. Lett., 2008, 18, 3955; (b) Y. Ogino, N.
Ohtake, Y. Nagae, K. Matsuda, M. Moriya, T. Suga, M. Ishikawa,
M. Kanesaka, Y. Mitobe, J. Ito, T. Kanno, A. Ishiara, H. Iwaasa, T.
Ohe, A. Kanatani and T. Fukami, Bioorg. Med. Chem. Lett., 2008,
18, 5010; (c) D. I. Shah, M. Sharma, Y. Bansal, G. Bansal and M.
Singh, Eur. J. Med. Chem., 2008, 43, 1808.
4
5
6
7d
73
60
90
7e
7f
7
7g 91
5 (a) R. Sarges, H. R. Howard, R. G. Browne, L. A. Lebel and P. A.
Seymour, J. Med. Chem., 1990, 33, 2240; (b) L. E. Seitz, W. J. Suling
and R. C. Reynolds, J. Med. Chem., 2002, 45, 5605; (c) A. Gazit, H.
App, G. McMahon, J. Chen, A. Levitzki and F. D. Bohmer, J. Med.
Chem., 1996, 39, 2170and references cited therein.
6 S. Dailey, J. W. Feast, R. J. Peace, I. C. Sage, S. Till and E. L. Wood,
J. Mater. Chem., 2001, 11, 2238.
7 (a) L. S. Jonathan, M. Hiromitsu, M. Toshihisa, M. L. Vincent and
F. Hiroyuki, Chem. Commun., 2002, 862; (b) L. S. Jonathan, M.
Hiromitsu, M. Toshihisa, M. L. Vincent and F. Hiroyuki, J. Am.
Chem. Soc., 2002, 124, 13474; (c) O. Sascha and F. Rudiger, Synlett,
2004, 1509.
8 (a) M. R. Grimmet, Comprehensive Heterocyclic Chemistry, (Ed.:
A. R. KatritzkyC. W. Rees, K. T. Potts,), Pergamon Press, New York,
1984, Vol. 5; (b) P. N. Preston, Chemistry, of Heterocyclic Compounds
(Ed.: A. Weissberger, E. C. Taylor, John Wiley and Sons, 1981, Vol.
40; (c) L. M. Dudd, E. Venardou, E. Garcia-Verdugo, P. Licence,
A. J. Blake, C. Wilson and M. Poliakoff, Green Chem., 2003, 5, 187.
9 R. J. Perry and B. D. Wilson, J. Org. Chem., 1993, 58, 7016.
10 C. T. Brain and S. A. Brunton, Tetrahedron Lett., 2002, 43, 1893.
11 D. Anastasiou, E. M. Campi, H. Chaouk and W. R. Jackson,
Tetrahedron, 1992, 48, 7467.
a Reaction conditions: 0.6 mmol 1a, 0.5 mmol 6 and 0.5 mmol TMSCl
mixed in 2 mL H2O, stirred at 70 ◦C for 8 h. b Yield of purified products
based on 6.
128.59, 128.50, 124.24, 123.44, 120.78, 112.14, 46.25; ESI-MS
[M+H+]: m/z = 353.
Typical procedure for the synthesis of quinoxalines in water
0.6 mmol diamine 1a and 0.5 mmol a-bromoketone 6 were
located in a round bottom flask with 2 mL water, and 0.5 mmol
TMSCl was added. The reaction was stirred at 70 ◦C for
8 h. After cooled down to room temperature, the mixture
was extracted with 3 ¥ 8 mL AcOEt. The combined organic
phase was dried with anhydrous sodium sulfate. After removing
the organic solvent, the residue was subjected to silical gel
chromatography to give pure products.
12 D. L. Yang, D. Fokas, J. Z. Li, L. B. Yu and C. M. Baldino, Synthesis,
2005, 47.
13 Z. Wu, P. Rea and G. Wickam, Tetrahedron Lett., 2000, 41, 9871.
14 (a) For selected examples in selective synthesis of 2-substituted ben-
zimidazole using o-phenylenediamine and aldehyde, seeR. Trivedi,
S. K. De and R. A. Gibbs, J. Mol. Catal. A: Chem., 2006, 245, 8;
(b) P. L. Beaulieu, B. Hache and E. Von Moos, Synthesis, 2003, 1683;
(c) K. Bahrami, M. M. Khodaei and I. Kavianinia, Synthesis, 2007,
2-phenylquinoxaline (7a). Pale orange solid; mp: 75–76 ◦C;17c
1H NMR (DMSO-d6, 500 MHz) d 9.59 (s, 1 H), 8.35 (d, 2 H,
1636 | Green Chem., 2009, 11, 1633–1637
This journal is
The Royal Society of Chemistry 2009
©